BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35267524)

  • 1. Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma.
    Plesca I; Benešová I; Beer C; Sommer U; Müller L; Wehner R; Heiduk M; Aust D; Baretton G; Bachmann MP; Feldmann A; Weitz J; Seifert L; Seifert AM; Schmitz M
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer.
    Kießler M; Plesca I; Sommer U; Wehner R; Wilczkowski F; Müller L; Tunger A; Lai X; Rentsch A; Peuker K; Zeissig S; Seifert AM; Seifert L; Weitz J; Bachmann M; Bornhäuser M; Aust D; Baretton G; Schmitz M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc
    Wagner F; Hölig U; Wilczkowski F; Plesca I; Sommer U; Wehner R; Kießler M; Jarosch A; Flecke K; Arsova M; Tunger A; Bogner A; Reißfelder C; Weitz J; Schäkel K; Troost EGC; Krause M; Folprecht G; Bornhäuser M; Bachmann MP; Aust D; Baretton G; Schmitz M
    Front Immunol; 2019; 10():602. PubMed ID: 30984181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
    Sosa Cuevas E; Valladeau-Guilemond J; Mouret S; Roubinet B; de Fraipont F; Landemarre L; Charles J; Bendriss-Vermare N; Chaperot L; Aspord C
    Front Immunol; 2022; 13():1040600. PubMed ID: 36353633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor.
    Tjomsland V; Spångeus A; Sandström P; Borch K; Messmer D; Larsson M
    PLoS One; 2010 Oct; 5(10):e13441. PubMed ID: 20976171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated human dendritic cell subsets: Phenotype, functional orientation, and clinical relevance.
    Plesca I; Müller L; Böttcher JP; Medyouf H; Wehner R; Schmitz M
    Eur J Immunol; 2022 Nov; 52(11):1750-1758. PubMed ID: 35106759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?
    Tjomsland V; Sandström P; Spångeus A; Messmer D; Emilsson J; Falkmer U; Falkmer S; Magnusson KE; Borch K; Larsson M
    BMC Cancer; 2010 Mar; 10():87. PubMed ID: 20214814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry.
    van der Hoorn IAE; Martynova E; Subtil B; Meek J; Verrijp K; Textor J; Flórez-Grau G; Piet B; van den Heuvel MM; de Vries IJM; Gorris MAJ
    Eur J Immunol; 2024 Jan; 54(1):e2350616. PubMed ID: 37840200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDCA1
    Sosa Cuevas E; Ouaguia L; Mouret S; Charles J; De Fraipont F; Manches O; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
    Clin Transl Immunology; 2020; 9(11):e1190. PubMed ID: 33282290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
    Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
    Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically applicable CD34
    van Eck van der Sluijs J; van Ens D; Thordardottir S; Vodegel D; Hermens I; van der Waart AB; Falkenburg JHF; Kester MGD; de Rink I; Heemskerk MHM; Borst J; Schaap NPM; Jansen JH; Xiao Y; Dolstra H; Hobo W
    Cancer Immunol Immunother; 2021 Nov; 70(11):3167-3181. PubMed ID: 33796917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.
    Sittig SP; van Beek JJP; Flórez-Grau G; Weiden J; Buschow SI; van der Net MC; van Slooten R; Verbeek MM; Geurtz PBH; Textor J; Figdor CG; de Vries IJM; Schreibelt G
    Eur J Immunol; 2021 Jun; 51(6):1494-1504. PubMed ID: 33675038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
    Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
    Front Immunol; 2021; 12():643529. PubMed ID: 33679807
    [No Abstract]   [Full Text] [Related]  

  • 14. Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment.
    Lucarini V; Melaiu O; Tempora P; D'Amico S; Locatelli F; Fruci D
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.
    Toma M; Wehner R; Kloß A; Hübner L; Fodelianaki G; Erdmann K; Füssel S; Zastrow S; Meinhardt M; Seliger B; Brech D; Noessner E; Tonn T; Schäkel K; Bornhäuser M; Bachmann MP; Wirth MP; Baretton G; Schmitz M
    Oncoimmunology; 2015 Jun; 4(6):e1008342. PubMed ID: 26155414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer.
    Sasaki K; Takano S; Tomizawa S; Miyahara Y; Furukawa K; Takayashiki T; Kuboki S; Takada M; Ohtsuka M
    J Exp Clin Cancer Res; 2021 Jun; 40(1):212. PubMed ID: 34167573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
    Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
    Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
    Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
    Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).
    Lianyuan T; Dianrong X; Chunhui Y; Zhaolai M; Bin J
    Cancer Biol Ther; 2018 Apr; 19(4):296-305. PubMed ID: 29313457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2.
    Scott CL; Soen B; Martens L; Skrypek N; Saelens W; Taminau J; Blancke G; Van Isterdael G; Huylebroeck D; Haigh J; Saeys Y; Guilliams M; Lambrecht BN; Berx G
    J Exp Med; 2016 May; 213(6):897-911. PubMed ID: 27185854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.